Abstract | BACKGROUND: OBJECTIVE: The purpose of this study was to assess the effect of CRT-D on VTA burden in LBBB patients. METHODS: RESULTS: During a mean follow-up of 2.5 years, 964 VTA episodes occurred in 264 patients (21%). The VTA rate per 100 person-years was significantly lower in the CRT-D group compared with the implantable cardioverter-defibrillator (ICD) group (20 vs 34; P <.01). Multivariate analysis demonstrated that CRT-D treatment was associated with a 32% risk reduction for VTA recurrence (hazard ratio 0.68; 95% confidence interval 0.57-0.82; P <.001), 57% risk reduction for recurrent life-threatening VTA, 54% risk reduction for recurrent appropriate ICD shocks, and 25% risk reduction for the combined endpoint of VTA and death. The effect of CRT-D on VTA burden was consistent among all tested subgroups but was more pronounced among patients in New York Heart Association functional class I. Landmark analysis showed that at 2 years, the cumulative probability of death subsequent to year one was highest (16%) among patients who had ≥2 VTA events during their first year. CONCLUSION: In patients with LBBB and HF, early intervention with CRT-D reduces mortality, VTA burden, and frequency of multiple appropriate ICD shocks. VTA burden is a powerful predictor of subsequent mortality.
|
Authors | Sinan Tankut, Ilan Goldenberg, Valentina Kutyifa, Wojciech Zareba, Nicola Luigi Bragazzi, Scott McNitt, David T Huang, Mehmet K Aktas, Arwa Younis |
Journal | Heart rhythm
(Heart Rhythm)
Vol. 18
Issue 5
Pg. 762-769
(05 2021)
ISSN: 1556-3871 [Electronic] United States |
PMID | 33440249
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved. |
Topics |
- Aged
- Canada
(epidemiology)
- Cardiac Resynchronization Therapy
(methods)
- Female
- Follow-Up Studies
- Humans
- Incidence
- Male
- Middle Aged
- Survival Rate
(trends)
- Tachycardia, Ventricular
(epidemiology, therapy)
- Treatment Outcome
- United States
(epidemiology)
|